Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSBR | PYPD | VRCA | ||
| Company | Champions Oncolog | Polypid Ltd | Verrica Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.70 | 4.34 | 4.43 | ||
| High | 5.92 | 4.45 | 4.87 | ||
| Low | 5.70 | 4.20 | 4.43 | ||
| Latest | 5.84 | 4.21 | 4.76 | ||
| Change | +0.10 | -0.07 | +0.38 | ||
| % Change | +1.74% | -1.64% | +8.68% | ||
| Volume | 7,100 | 72,500 | 68,900 | ||
| 20-Day Average Volume | 9,700 | 53,255 | 143,775 | ||
| Previous Close | 5.74 | 4.28 | 4.38 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.92 | 4.27 | 5.40 | ||
| 20-Day Raw Stochastic | 40.48% | 27.48% | 22.25% | ||
| 20-Day Relative Strength | 45.52 | 47.26 | 39.55 | ||
| Weighted Alpha | -15.23 | +57.29 | -68.06 | ||
| Today's Opinion | 100% Sell | 40% Buy | 56% Sell | ||
| Previous Opinion | 100% Sell | 56% Buy | 56% Sell | ||
| Last Month's Opinion | 72% Sell | 56% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.01% since 03/23/26 | +1.45% since 03/23/26 | -1.86% since 03/23/26 | ||
| Low | 5.65 on 03/27/26 | 4.03 on 03/24/26 | 4.24 on 03/24/26 | ||
| High | 5.97 on 03/24/26 | 4.47 on 03/27/26 | 5.20 on 03/24/26 | ||
| 1-Month | |||||
| %Chg | -1.93% since 02/27/26 | -0.94% since 02/27/26 | -12.98% since 02/27/26 | ||
| Low | 5.50 on 03/13/26 | 4.01 on 03/02/26 | 4.24 on 03/24/26 | ||
| High | 6.34 on 03/17/26 | 4.68 on 03/17/26 | 6.56 on 03/12/26 | ||
| 3-Month | |||||
| %Chg | -16.33% since 12/26/25 | +3.44% since 12/26/25 | -41.67% since 12/26/25 | ||
| Low | 5.50 on 03/13/26 | 4.01 on 03/02/26 | 4.24 on 03/24/26 | ||
| High | 7.71 on 01/28/26 | 5.12 on 02/03/26 | 9.02 on 12/30/25 | ||
| 6-Month | |||||
| %Chg | -7.30% since 09/26/25 | +26.24% since 09/26/25 | +13.88% since 09/26/25 | ||
| Low | 5.50 on 03/13/26 | 3.06 on 10/10/25 | 3.28 on 11/04/25 | ||
| High | 8.31 on 12/15/25 | 5.12 on 02/03/26 | 9.82 on 11/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 79,711 | 81,675 | 75,244 | ||
| Shares Outstanding, K | 13,887 | 19,083 | 17,179 | ||
| Annual Sales | 56,940,000 | 0 | 35,580,000 | ||
| Annual Net Income | 4,700,000 | -34,170,000 | -17,890,000 | ||
| Last Quarter Sales | 16,560,000 | 0 | 5,090,000 | ||
| Last Quarter Net Income | -280,000 | -8,470,000 | -8,070,000 | ||
| 60-Month Beta | 0.38 | 1.49 | 1.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 03/12/26 | -0.41 on 02/11/26 | -0.51 on 03/11/26 | ||
| Latest Earnings Date | 07/22/26 | 05/13/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||